XO
XOMA Royalty Corp.
XOMA · NASDAQ
$40.17 -7.72% (-$3.36)
Market Cap $503.8M
P/E Ratio 29.16x
Div. Yield -
ROE 29.40%
Bulios Fair Price
$54.84
36.5% upside
Current Price
$40.17
Undervalued Fair Value Overvalued
According to Bulios Fair Price, XOMA is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
33 /100
Expensive P/E 29.16x
EV/EBITDA 14.92x
P/FCF 34.95x
Growth
6 /100
Declining Rev. growth 45.50%
Book val. growth 0.88%
EPS growth N/A
Profitability
92 /100
Strong Gross margin 94.14%
Net margin 54.77%
FCF margin 28.42%
Quality
53 /100
Average ROIC 3.70%
ROE 29.40%
Asset turnover 0.19x
Debt
69 /100
Low Debt/Equity 1.34x
Current ratio 3.59x
Net debt/EBITDA 1.08x
Stability
28 /100
Unstable Beta 0.87x
Rev. volatility 57.14%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about XOMA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Owen Hughes Jr.
Employees
14
Headquarters
EmeryVille